Sign in
4

Changes in Ownership

Inhibikase Therapeutics, Inc. Filed Acc 0000950170-25-026652

Options or other derivatives

  • President & Head of R&D acquired 1,100,705 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cabell Christopher · President & Head of R&D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-21 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,100,705 1,100,705 D
Loading xslF345X05/ownership.xml…